Literature DB >> 3536921

Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A.

J O Kokkonen, M Vartiainen, P T Kovanen.   

Abstract

The secretory granules of rat serosal mast cells are able efficiently to degrade the apolipoprotein B component of low density lipoproteins (LDL) Kokkonen, J. O., and Kovanen, P. T. (1985) J. Biol. Chem. 260, 14756-14763). The granules are known to contain two neutral proteases with complementary specificities: a chymotrypsin-like endopeptidase called chymase, and an exopeptidase, the granule carboxypeptidase A. The role of this enzyme pair in the proteolytic degradation of LDL was studied with the aid of specific enzyme inhibitors. Incubation of LDL with intact granules (both enzymes active) led to the formation of numerous low molecular weight peptides and the liberation of free amino acids, most of which (95%) were aromatic (Phe, Tyr, Trp) or branched-chain aliphatic (Leu, Ile, Val). Selective inhibition of granule carboxypeptidase A (leaving chymase active) blocked the liberation of free amino acids, but left the formation of peptides uninhibited. On the other hand, selective inhibition of granule chymase (leaving carboxypeptidase A active) totally abolished the proteolytic degradation of LDL. The results are consistent with a model according to which the proteolytic degradation of LDL by mast cell granules results from coordinated action of the two granule-bound enzymes, whereby the chymase first cleaves peptides from the apolipoprotein B of LDL, and thereafter the carboxypeptidase A cleaves amino acids from the peptides formed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536921

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Regulation and function of mast cell proteases in inflammation.

Authors:  C Huang; A Sali; R L Stevens
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

2.  Cloning and characterization of the novel gene for mast cell carboxypeptidase A.

Authors:  D S Reynolds; D S Gurley; K F Austen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 3.  Mast cell polymorphisms. Present concepts, future directions.

Authors:  D Befus; H Fujimaki; T D Lee; M Swieter
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

4.  Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.

Authors:  T Kajita; T E Hugli
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease.

Authors:  Łukasz Lewicki; Janusz Siebert; Tomasz Koliński; Karolina Piekarska; Magdalena Reiwer-Gostomska; Radosław Targoński; Piotr Trzonkowski; Natalia Marek-Trzonkowska
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

6.  Identification of aminopeptidase activity in the secretory granules of mouse mast cells.

Authors:  W E Serafin; U A Guidry; E T Dayton; M M Kamada; R L Stevens; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

7.  Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.

Authors:  Donald D Smith; Xiaoyu Tan; Vineesh V Raveendran; Ossama Tawfik; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-13       Impact factor: 4.733

8.  An immune response network associated with blood lipid levels.

Authors:  Michael Inouye; Kaisa Silander; Eija Hamalainen; Veikko Salomaa; Kennet Harald; Pekka Jousilahti; Satu Männistö; Johan G Eriksson; Janna Saarela; Samuli Ripatti; Markus Perola; Gert-Jan B van Ommen; Marja-Riitta Taskinen; Aarno Palotie; Emmanouil T Dermitzakis; Leena Peltonen
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

9.  Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.

Authors:  G Pejler; K Söderström; A Karlström
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

10.  Proteolysis of human growth hormone by rat thyroid gland in vitro: application of electrospray mass spectrometry and N-terminal sequencing to elucidate a metabolic pathway.

Authors:  V J Wroblewski; R E Kaiser; G W Becker
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.